Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00419250. IPD Sharing: Not stated. Countries: 7. Publications: 1.
CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.
ClinicalTrials.gov study NCT02132624. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)
ClinicalTrials.gov study NCT01213095. IPD Sharing: Not stated. Countries: 1. Publications: 1.
TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL
ClinicalTrials.gov study NCT06014073. IPD Sharing: NO. Countries: 1. Publications: 1.
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00831597. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma
ClinicalTrials.gov study NCT00169195. IPD Sharing: Not stated. Countries: 1. Publications: 6.
JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT06045585. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19
ClinicalTrials.gov study NCT01864889. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)
ClinicalTrials.gov study NCT04404660. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00169169. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Investigator Initiated Study to Assess the Safety of Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion.
ClinicalTrials.gov study NCT07361224. IPD Sharing: UNDECIDED. Countries: 0. Publications: 4.
A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)
ClinicalTrials.gov study NCT00779883. IPD Sharing: Not stated. Countries: 1. Publications: 51.
A Study Comparing the Efficacy and Safety Between I-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients
ClinicalTrials.gov study NCT02867566. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine
ClinicalTrials.gov study NCT00310713. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma
ClinicalTrials.gov study NCT04014894. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation
ClinicalTrials.gov study NCT01445132. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies
ClinicalTrials.gov study NCT01905813. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT02763319. IPD Sharing: YES. Countries: 23. Publications: 0.
CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease
ClinicalTrials.gov study NCT06347718. IPD Sharing: NO. Countries: 1. Publications: 1.
STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT01653067. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.